Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 Aug;6(8):27-8.

The use of duloxetine in chronic bulimia nervosa: a case report

Richard C Christensen  1 , Robert N Averbuch
Affiliations
Case Reports

The use of duloxetine in chronic bulimia nervosa: a case report

Richard C Christensen et al. Psychiatry (Edgmont). 2009 Aug.

Abstract

Selective serotonin reuptake inhibitors are routinely prescribed as off-label treatments for bulimia nervosa. There is, however, a paucity of literature addressing the efficacy of the serotonin norepinephrine reuptake inhibitors in the pharmacologic management of this disorder. This article describes a clinical situation in which duloxetine, a serotonin norepinephrine reuptake inhibitor, effectively treated a patient with long-standing bulimia nervosa, purging type, and comorbid generalized anxiety disorder.

Keywords: Bulimia nervosa; duloxetine; pharmacological management; serotonin norepinephrine reuptake inhibitors; serotonin reuptake inhibitors.

PubMed Disclaimer

References

    1. Ashih HW. Effective psychiatric medications for eating disorders. Carlat Psychiatry Rep. 2009;7(5):1–3.
    1. Leombruni P, Lavagnino L, Gastaldi F, et al. Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial. Hum Psychopharmacol. 2009 Jun 18; (Epub ahead of print) - PubMed
    1. Hazen E, Fava M. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. J Psychopharmacol. 2006;20(5):723. - PubMed
    1. Milano W, Petrella C, Sabatino C, et al. Treatment of bulimia nervosa with sertraline: a randomized controlled trial. Adv Therapeutics. 2004;21(4):232–237. - PubMed
    1. Milano W, Siano C, Petrella C, et al. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Therapeutics. 2005;22(3):278–283. - PubMed

Publication types

LinkOut - more resources